Literature DB >> 17010535

Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine.

Mladen Vassilev Tzvetkov1, Cornelia Meineke, Elke Oetjen, Karen Hirsch-Ernst, Jürgen Brockmöller.   

Abstract

The serotonin receptor type 3 is a pentameric ligand-gated ion channel regulating intestinal motility, nausea, and vomiting in humans. The HTR3B gene codes for the subunit B of this receptor. The HTR3B transcription start site is not unequivocally identified. In the present study we used transcription start site analyses, transcript-specific RT-PCR, and functional promoter analyses to identify the 5' structure of the HTR3B gene. According to these experiments, two alternative promoters control the expression of different HTR3B transcripts in the peripheral and central nervous system. The transcription start sites observed in the intestine corresponded to the current human genome annotation (NCBI Build 36.1, March 2006). The transcription start sites in the brain, however, were localized in a region about 4000 bp downstream. The brain transcripts lacked the coding first exon of the HTR3B structure published earlier but had an upstream-extended exon 2 containing a new potential translational start site. Reporter gene analyses showed significant promoter activity of the genomic region located 1560 bp upstream to 93 bp downstream of the brain-specific transcription start sites. This data suggests a different transcriptional regulation of the HTR3B gene in the peripheral and the central nervous system that leads to the expression of transcripts with variations in the 5' coding sequence. Further studies on the expression, structure and function of therefore expected tissue-specific 5-HT(3B) isoforms are required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010535     DOI: 10.1016/j.gene.2006.08.002

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  20 in total

1.  Differential expression of the 5-HT(3A) and 5-HT(3B) receptor in differentiated NG108-15 cells.

Authors:  Hajime Asano; Akinori Miyamoto; Mariko Nakao; Chiyuki Wakaki; Takuma Iida; Yoshinori Funakami; Tetsuyuki Wada; Seiji Ichida
Journal:  Neurochem Res       Date:  2012-04-26       Impact factor: 3.996

Review 2.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 3.  The 5-HT3 receptor as a therapeutic target.

Authors:  Andrew J Thompson; Sarah C R Lummis
Journal:  Expert Opin Ther Targets       Date:  2007-04       Impact factor: 6.902

Review 4.  Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

Authors:  Tina K Machu
Journal:  Pharmacol Ther       Date:  2011-02-26       Impact factor: 12.310

5.  Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor.

Authors:  S C R Lummis; A J Thompson; M Bencherif; H A Lester
Journal:  J Pharmacol Exp Ther       Date:  2011-07-20       Impact factor: 4.030

6.  Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity.

Authors:  Elena Shumay; Joanna S Fowler; Nora D Volkow
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

Review 7.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

Review 8.  3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors.

Authors:  Anders A Jensen; Paul A Davies; Hans Bräuner-Osborne; Karen Krzywkowski
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

9.  Direct subunit-dependent multimodal 5-hydroxytryptamine3 receptor antagonism by methadone.

Authors:  Tarek Z Deeb; Douglas Sharp; Tim G Hales
Journal:  Mol Pharmacol       Date:  2009-01-08       Impact factor: 4.436

Review 10.  Serotonin pharmacology in the gastrointestinal tract: a review.

Authors:  D T Beattie; J A M Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.